#69 Injection Update IM and SQ #69 Injection Update IM and SQ #69 Injection Update IM and SQ CE 2.0 Total | 2.0 of which are…Jose CorreaSeptember 10, 2020
#68 GI Part-2 GI Function and Therapeutics #68 GI Part-2 GI Function and Therapeutics #68 GI Part-2 GI Function and Therapeutics CE 1.5 Total | 1.0 of which…Jose CorreaSeptember 10, 2020
#67 Immunology Part-4 Natural Immunologic Agents #67 Immunology Part-4 Natural Immunologic Agents #67 Immunology Part-4 Natural Immunologic Agents CE 2.0 Total | 2.0 of which are…Jose CorreaSeptember 10, 2020
#66 Controversies in Oncology #66 Controversies in Oncology #66 Controversies in Oncology CE 2.0 Total | 1.5 of which are Pharm Controversies…Jose CorreaSeptember 10, 2020
#64 PHARM Part-20 Repurposed Drugs in Oncology #64 PHARM Part-20 Repurposed Drugs in Oncology #64 PHARM Part-20 Repurposed Drugs in Oncology CE 1.5 Total | 1.5 of which…Jose CorreaSeptember 10, 2020
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases #63 Assessment Part-6 Managing Comorbidity in Chronic Cases #63 Assessment Part-6 Managing Comorbidity in Chronic Cases CE 1.5 Total | 0.5 of…Jose CorreaSeptember 10, 2020
#62 COVID-19 Part-1 Clinician Updates #62 COVID-19 Part-1 Clinician Updates #62 COVID-19 Part-1 Clinician Updates CE 2.0 Total | 1.5 of which are Pharm…Jose CorreaSeptember 10, 2020
#60 PHARM Part-19 Advanced Adrenal Assessment and Therapeutics #60 PHARM Part-19 Advanced Adrenal Assessment and Therapeutics #60 PHARM Part-19 Advanced Adrenal Assessment and Therapeutics CE 1.5 Total | 1.0 of…Jose CorreaSeptember 10, 2020
#44 PHARM Part-15 Acute Use of Thyroid and Adrenal-RX #44 PHARM Part-15 Acute Use of Thyroid and Adrenal-RX #44 PHARM Part-15 Acute Use of Thyroid and Adrenal-RX CE 2.0 Total | 2.0…Jose CorreaSeptember 10, 2020
#46 Respiratory Pharmacology Part-2 Natural Therapies Nebulizer and others #46 Respiratory Pharmacology Part-2 Natural Therapies Nebulizer and others #46 Respiratory Pharmacology Part-2 Natural Therapies Nebulizer and others CE 1.5 Total | 1.5…Jose CorreaSeptember 10, 2020
#42 PHARM Part-14 NAD Therapies #42 PHARM Part-14 NAD Therapies #42 PHARM Part-14 NAD Therapies CE 1.5 Total | 1.5 of which are Pharm…Jose CorreaSeptember 10, 2020
#30 NEURO Part-1 Neurological Therapies #30 NEURO Part-1 Neurological Therapies #30 NEURO Part-1 Neurological Therapies CE 1.5 Total | 0.5 of which are Pharm…Jose CorreaSeptember 10, 2020
#29 PHARM Part-12 Medical Cannabinoids Pharmacology and Clinical Use #29 PHARM Part-12 Medical Cannabinoids Pharmacology and Clinical Use #29 PHARM Part-12 Medical Cannabinoids Pharmacology and Clinical Use CE 1.5 Total | 1.5…Jose CorreaSeptember 10, 2020
#28 Immunology Part-1 Low Dose Naltrexone #28 Immunology Part-1 Low Dose Naltrexone #28 Immunology Part-1 Low Dose Naltrexone CE 1.5 Total | 1.5 of which are Pharm…Jose CorreaSeptember 10, 2020
#32 HBOT-1 Hyperbaric Oxygen Therapies General #32 HBOT-1 Hyperbaric Oxygen Therapies General #32 HBOT-1 Hyperbaric Oxygen Therapies General CE 1.5 Total | 1.0 of which are…Jose CorreaSeptember 10, 2020
#35 PHARM Part-13 Migraine Assessment and Treatment #35 PHARM Part-13 Migraine Assessment and Treatment #35 PHARM Part-13 Migraine Assessment and Treatment CE 2.0 Total | 1.5 of which…Jose CorreaSeptember 10, 2020
#38 GI Part-1 Nutrient Absorption and GI Health #38 GI Part-1 Nutrient Absorption and GI Health #38 GI Part-1 Nutrient Absorption and GI Health CE 1.5 Total | 0.5 of…Jose CorreaSeptember 10, 2020
#36 PCOS #36 PCOS #36 PCOS CE 1.5 Total | 1.0 of which are Pharm PCOS – Assessment…Jose CorreaSeptember 10, 2020
#37 Detoxification Part-2 Fluoroquinolone Toxicity #37 Detoxification Part-2 Fluoroquinolone Toxicity #37 Detoxification Part-2 Fluoroquinolone Toxicity CE 1.5 Total | 1.5 of which are Pharm…Jose CorreaSeptember 10, 2020
#41 Detoxification Part-3 Detox of Unusual Metals #41 Detoxification Part-3 Detox of Unusual Metals #41 Detoxification Part-3 Detox of Unusual Metals CE 1.5 Total | 1.5 of which…Jose CorreaSeptember 10, 2020
#40 Immunology Part-2 Low Dose Immunotherapy (LDI) #40 Immunology Part-2 Low Dose Immunotherapy (LDI) #40 Immunology Part-2 Low Dose Immunotherapy (LDI) CE 1.5 Total | 1.5 of which…Jose CorreaSeptember 10, 2020
#39 NEURO Part-2 Dysautonomia and EDS #39 NEURO Part-2 Dysautonomia and EDS #39 NEURO Part-2 Dysautonomia and EDS CE 1.5 Total | 0.5 of which are…Jose CorreaSeptember 10, 2020
#27 PHARM Part-11 Seizure (Epilepsy) Medication Pharmacology and Weaning #27 PHARM Part-11 Seizure (Epilepsy) Medication Pharmacology and Weaning #27 PHARM Part-11 Seizure (Epilepsy) Medication Pharmacology and Weaning CE 1.5 Total | 1.5…Jose CorreaSeptember 10, 2020
#25 IV Injection Q&A Part-2 #25 IV Injection Q&A Part-2 #25 IV Injection Q&A Part-2 CE 1.5 Total | 1.5 of which are Pharm…Jose CorreaSeptember 10, 2020
#26 PHARM Part-10 ADHD Medication Pharmacology and Weaning #26 PHARM Part-10 ADHD Medication Pharmacology and Weaning #26 PHARM Part-10 ADHD Medication Pharmacology and Weaning CE 1.5 Total | 1.5 of…Jose CorreaSeptember 10, 2020